Article
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.
JAMA network open - 2 Sept 2025
Mahadevia Himil, Majeed Umair, Patel Jaydeepbhai, Ahmed Ahmed K, Elhariri Ahmed, Albelal Douaa, Rao Nakka Naga Malleswara, Rachamala Hari Krishnareddy, Mosalem Osama, Mukhopadhyay Debabrata, Jones Jeremy, Mahadevan Daruka, Borad Mitesh J, Ahn Daniel, Sonbol Mohamad Bassam, Tran Nguyen, Mahipal Amit, Wee Ma Wen, McWilliams Robert R, Halfdanarson Thor R, Kankeu Fonkoua Lionel A, Bekaii-Saab Tanios, Mody Kabir, Babiker Hani
Abstract excerpt
Importance: The prognosis of advanced pancreaticobiliary tumors is poor. Next-generation sequencing (NGS) of tissue samples is utilized to identify actionable alterations, but there are occasional limitations due to inadequate tissue acquisition. Circulating tumor DNA (ctDNA) is an alternative method, but its correlation with tissue-based NGS remains unexplored. Objectives: To assess the mutation concordance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
